| 摘要 |
The present invention is directed to the combination of a muscarinic receptor antagonist and a corticosteroid, and the use of said combination in treating diseases mediated via the M3 muscarinic acetylcholine receptor and/or the glucocorticoid receptor, such as asthma. |
